Getting Out of the House: Using Behavioral Activation to Increase Community Participation
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Temple University
- Study ID
- NCT06336616
- Status
- Recruiting
Conditions
- Bipolar Disorder
- Major Depressive Disorder
- Schizo Affective Disorder
- Schizophrenia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Behavior Activation — BEHAVIORALParticipants will be taught to identify meaningful activities, set goals, use environmental cues, self-reward, to identify barriers and facilitators, and learn new skills to support them to develop self-management skills and new habits.
Study Details
The goal of this study is to evaluate the effectiveness of an behavioral activation intervention to increase meaningful activity and community participation for people with serious mental illness. The overall objective of this study is to increase engagement in meaningful activities and community participation. The objectives of the project are as follows: 1. To determine if the intervention leads to increases the frequency and variety of activities. 2. To determine if the intervention leads to increases in community mobility. 3. To determine which demographic and environmental factors and mechanisms of action impact the effectiveness of the intervention. 4. To determine if the the intervention leads to an improvement in overall well-being (e.g., improved quality of life). Participants will be asked to attend a 2-hour weekly online session for 10 weeks and then a 1-hour online monthly session for a 3 month maintenance period. For data collection, participants will also be asked to: 1. Complete three, approximately 1-hour interviews at baseline, after the 10 week intervention, and again at the end of the maintenance period; 2. Carry a mobile phone with a global positioning system app to track their movements outside their home for 2 weeks at a time, at three separate times (e.g., baseline, after the intervention, and at the end of the maintenance period); and 3. Complete a 15 minute weekly interviews for 26 weeks about their daily activities and participation. The study will enroll 52 participants split into 4 cohorts of 13. The study will use a multiple baseline design and, as such, all participants will receive the intervention and there is no control group.
Key Dates
- Start date
- Feb 15, 2024
- Status verified
- Apr 2024
- Primary completion
- Aug 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- NA
- Intervention model
- SEQUENTIAL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Intervention groupAll participants will receive an online behavioral intervention for 10 weeks, followed by monthly maintenance sessions for 3 months.
Primary Outcome Measure
Activity Logs [ Time Frame: administered 26 times: 1 time per week for 26 weeks. ]
Central Contacts
- Crystal Slanzi, PhD(215) 204-9664
- Mark Salzer, PhD(215) 204-7879
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Temple University | Philadelphia | Pennsylvania | 19120 | Crystal Slanzi |
Find similar trials in Philadelphia, PA
Related Studies
- Zyprexa® Relprevv™ Patient Care ProgramEnrolling By Invitation · Eli Lilly and Company · Blue Bell, Pennsylvania
- Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as CorrelatesPHASE4 · Recruiting · Corporal Michael J. Crescenz VA Medical Center · Philadelphia, Pennsylvania
- Bromocriptine for Patients With Schizophrenia and PrediabetesPHASE4 · Not Yet Recruiting · VA Pittsburgh Healthcare System · Pittsburgh, Pennsylvania
- Cromoglicate Adjunctive Therapy for Outpatients With SchizophreniaPHASE1/PHASE2 · Recruiting · Vishwajit Nimgaonkar, MD PhD · Pittsburgh, Pennsylvania